iTeos Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
iTeos Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • iTeos Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $74.4M, a 63.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $74.4M +$29M +63.8% Dec 31, 2023 10-K 2024-03-06
Q4 2022 $45.4M +$18.8M +70.5% Dec 31, 2022 10-K 2024-03-06
Q4 2021 $26.6M -$5.38M -16.8% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $32M +$10.4M +47.8% Dec 31, 2020 10-K 2022-03-23
Q4 2019 $21.7M Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.